// App-Quantinova.ai

: Successful of Chemo-Free Treatment with Dasatinib and Blinatumomab in a Pediatric EBF1-PDGFRβ Positive Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Fara Petruzziello

Principal Investigators

  • Giovanna Giagnuolo

  • Giovanni Cazzaniga

  • Giuliana Beneduce

  • Franco Locatelli

  • Pio Stellato

  • Grazia Fazio

  • Giuseppe Mirabelli

  • Giuseppe Menna

  • Rosanna Parasole

Medical Centers

  • Department of Pediatric Hemato-Oncology, Santobono-Pausilipon Hospital, Naples, Italy

  • Department of Pediatric Hemato-Oncology, Santobono-Pausilipon Hospital, Naples, Italy

  • Centro Ricerca Tettamanti, Clinica Pediatrica Univ. Milano Bicocca Ospedale San Gerardo, Monza, Italy

  • Department of Pediatric Hemato-Oncology, Santobono-Pausilipon Hospital, Naples, Italy

  • University of Pavia, Pavia, Italy

  • Department of Pediatric Hematology and Oncology, Cell and Gene Therapy,IRCCS Bambino Gesù Children's Hospital,Roma,Italy

  • Department of Pediatric Hemato-Oncology, Santobono-Pausilipon Hospital, Naples, Italy

  • Tettamanti Research Center, Monza, ITA

  • IRCCS SDN, Napoli, Naples, Italy

  • Pediatric Hematology Unit, Santobono-Pausilipon Hospital, Naples, Italy

  • Department of Pediatric Hemato-Oncology, Santobono-Pausilipon Hospital, Naples, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Infectious Diseases (ID)

Disease

  • Acute lymphoblastic leukemia

  • Sepsis

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Pegaspargase

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Blinatumomab

  • Daunorubicin

  • Methotrexate

  • Asparaginase

  • Vincristine

  • Cytarabine liposomal

  • Prednisone

  • dasatinib

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Observational

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved